|
|
G Tiao, S Hobler, J J Wang, T A Meyer, F A Luchette, J E Fischer, P O Hasselgren
J Clin Invest. 1997;
99(2):163
doi:10.1172/JCI119143
Abstract |
Full text
| PDF

P
revious studies provided evidence that sepsis-induced muscle proteolysis in experimental animals is caused by increased ubiquitin-proteasome-dependent protein breakdown. It is not known if a similar mechanism accounts for muscle proteolysis in patients with sepsis. We determined mRNA levels for ubiquitin and the 20 S proteasome subunit HC3 by Northern blot analysis in muscle tissue from septic (n = 7) and non-septic (n = 11) patients. Plasma and muscle amino acid concentrations and concentrations in urine of 3-methylhistidine (3-MH), creatinine, and cortisol were measured at the time of surgery to assess the catabolic state of the patients. A three- to fourfold increase in mRNA levels for ubiquitin and HC3 was noted in muscle tissue from the septic patients concomitant with increased muscle levels of phenylalanine and 3-MH and reduced levels of glutamine. Total plasma amino acids were decreased by approximately 30% in the septic patients. The 3-MH/creatinine ratio in urine was almost doubled in septic patients. The cortisol levels in urine were higher in septic than in control patients but this difference did not reach statistical significance. The results suggest that sepsis is associated with increased mRNAs of the ubiquitin-proteasome pathway in human skeletal muscle.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(74)
| Title and authors |
Publication |
Year |
Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis
Maria Klaude, Maiko Mori, Inga Tjäder, Thomas Gustafsson, Jan Wernerman, Olav Rooyackers
|
Clin. Sci.
|
2012 |
Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks
Simon S. Wing, Stewart H. Lecker, R. Thomas Jagoe
|
Critical Reviews in Clinical Laboratory Sciences
|
2011 |
Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats
Qiyi Chen, Ning Li, Weiming Zhu, Weiqin Li, Shaoqiu Tang, Wenkui Yu, Tao Gao, Juanjuan Zhang, Jieshou Li
|
J Inflamm
|
2011 |
Erworbene Muskelschwäche beim kritisch Kranken : Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie
K. Judemann, D. Lunz, Y.A. Zausig, B.M. Graf, W. Zink
|
Anaesthesist
|
2011 |
Structure to function: muscle failure in critically ill patients
Zudin Puthucheary, Hugh Montgomery, John Moxham, Stephen Harridge, Nicholas Hart
|
The Journal of Physiology
|
2010 |
Bioactive Peptides
|
Bioactive Peptides
|
2010 |
Increasing intravenous glucose load in the presence of normoglycemia: Effect on outcome and metabolism in critically ill rabbits
Sarah Derde, Ilse Vanhorebeek, Eric-Jan Ververs, Ine Vanhees, Veerle M. Darras, Erik Van Herck, Lars Larsson, Greet Van den Berghe
|
Critical Care Medicine
|
2010 |
Bioactive Peptides
|
Bioactive Peptides
|
2010 |
Sepsis downregulates myostatin mRNA levels without altering myostatin protein levels in skeletal muscle
Ira J. Smith, Zaira Aversa, Nima Alamdari, Victoria Petkova, Per-Olof Hasselgren
|
J. Cell. Biochem.
|
2010 |
Activation of the ubiquitin proteolytic pathway in human septic heart and diaphragm
Christophe Rabuel, Jane-Lise Samuel, Brice Lortat-Jacob, Françoise Marotte, Sophie Lanone, Christine Keyser, Arrigo Lessana, Didier Payen, Alexandre Mebazaa
|
Cardiovascular Pathology
|
2010 |
|